NCT05316077View on ClinicalTrials.gov

Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up

UnknownOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions

Oncology

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

Univ.-Klinik für Radiologie, Graz

RECRUITING

CHU-Hôpital François Mitterrand, Dijon

NOT_YET_RECRUITING

CHUV, Lausanne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Guerbet

INDUSTRY